India’s pharmaceutical market will see continued strong growth at a more favourable rate than its global peers and even if the country’s GDP growth were to slow down, it would still represent a better growth opportunity, according to Moody’s Investors Service.
from News Nation http://ift.tt/1l8HJ15
via IFTTT
from News Nation http://ift.tt/1l8HJ15
via IFTTT
No comments:
Post a Comment